Global Acute Myeloid Leukemia Treatment Market Growth 2018-2023

October 2018 | 134 pages | ID: G5F1C881FECEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age.
Over the next five years, LPI(LP Information) projects that Acute Myeloid Leukemia Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Acute Myeloid Leukemia Treatment market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Acute Myeloid Leukemia Treatment market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• DC regimen
• AVD Regimen
• VCD regimen

Segmentation by application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Ambit Biosciences Corporation
• Celgene Corporation
• Cephalon
• Clavis Pharma
• Eisai
• Genzyme Corporation
• Sunesis Pharmaceuticals
• ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Acute Myeloid Leukemia Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Acute Myeloid Leukemia Treatment market by identifying its various subsegments.
• Focuses on the key global Acute Myeloid Leukemia Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Acute Myeloid Leukemia Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Acute Myeloid Leukemia Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Acute Myeloid Leukemia Treatment Consumption 2013-2023
  2.1.2 Acute Myeloid Leukemia Treatment Consumption CAGR by Region
2.2 Acute Myeloid Leukemia Treatment Segment by Type
  2.2.1 DC regimen
  2.2.2 AVD Regimen
  2.2.3 VCD regimen
2.3 Acute Myeloid Leukemia Treatment Consumption by Type
  2.3.1 Global Acute Myeloid Leukemia Treatment Consumption Market Share by Type (2013-2018)
  2.3.2 Global Acute Myeloid Leukemia Treatment Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Acute Myeloid Leukemia Treatment Sale Price by Type (2013-2018)
2.4 Acute Myeloid Leukemia Treatment Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Acute Myeloid Leukemia Treatment Consumption by Application
  2.5.1 Global Acute Myeloid Leukemia Treatment Consumption Market Share by Application (2013-2018)
  2.5.2 Global Acute Myeloid Leukemia Treatment Value and Market Share by Application (2013-2018)
  2.5.3 Global Acute Myeloid Leukemia Treatment Sale Price by Application (2013-2018)

3 GLOBAL ACUTE MYELOID LEUKEMIA TREATMENT BY PLAYERS

3.1 Global Acute Myeloid Leukemia Treatment Sales Market Share by Players
  3.1.1 Global Acute Myeloid Leukemia Treatment Sales by Players (2016-2018)
  3.1.2 Global Acute Myeloid Leukemia Treatment Sales Market Share by Players (2016-2018)
3.2 Global Acute Myeloid Leukemia Treatment Revenue Market Share by Players
  3.2.1 Global Acute Myeloid Leukemia Treatment Revenue by Players (2016-2018)
  3.2.2 Global Acute Myeloid Leukemia Treatment Revenue Market Share by Players (2016-2018)
3.3 Global Acute Myeloid Leukemia Treatment Sale Price by Players
3.4 Global Acute Myeloid Leukemia Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Acute Myeloid Leukemia Treatment Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Acute Myeloid Leukemia Treatment Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ACUTE MYELOID LEUKEMIA TREATMENT BY REGIONS

4.1 Acute Myeloid Leukemia Treatment by Regions
  4.1.1 Global Acute Myeloid Leukemia Treatment Consumption by Regions
  4.1.2 Global Acute Myeloid Leukemia Treatment Value by Regions
4.2 Americas Acute Myeloid Leukemia Treatment Consumption Growth
4.3 APAC Acute Myeloid Leukemia Treatment Consumption Growth
4.4 Europe Acute Myeloid Leukemia Treatment Consumption Growth
4.5 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Growth

5 AMERICAS

5.1 Americas Acute Myeloid Leukemia Treatment Consumption by Countries
  5.1.1 Americas Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018)
  5.1.2 Americas Acute Myeloid Leukemia Treatment Value by Countries (2013-2018)
5.2 Americas Acute Myeloid Leukemia Treatment Consumption by Type
5.3 Americas Acute Myeloid Leukemia Treatment Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Acute Myeloid Leukemia Treatment Consumption by Countries
  6.1.1 APAC Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018)
  6.1.2 APAC Acute Myeloid Leukemia Treatment Value by Countries (2013-2018)
6.2 APAC Acute Myeloid Leukemia Treatment Consumption by Type
6.3 APAC Acute Myeloid Leukemia Treatment Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Acute Myeloid Leukemia Treatment by Countries
  7.1.1 Europe Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018)
  7.1.2 Europe Acute Myeloid Leukemia Treatment Value by Countries (2013-2018)
7.2 Europe Acute Myeloid Leukemia Treatment Consumption by Type
7.3 Europe Acute Myeloid Leukemia Treatment Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Acute Myeloid Leukemia Treatment by Countries
  8.1.1 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Acute Myeloid Leukemia Treatment Value by Countries (2013-2018)
8.2 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption by Type
8.3 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Acute Myeloid Leukemia Treatment Distributors
10.3 Acute Myeloid Leukemia Treatment Customer

11 GLOBAL ACUTE MYELOID LEUKEMIA TREATMENT MARKET FORECAST

11.1 Global Acute Myeloid Leukemia Treatment Consumption Forecast (2018-2023)
11.2 Global Acute Myeloid Leukemia Treatment Forecast by Regions
  11.2.1 Global Acute Myeloid Leukemia Treatment Forecast by Regions (2018-2023)
  11.2.2 Global Acute Myeloid Leukemia Treatment Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Acute Myeloid Leukemia Treatment Forecast by Type
11.8 Global Acute Myeloid Leukemia Treatment Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Ambit Biosciences Corporation
  12.1.1 Company Details
  12.1.2 Acute Myeloid Leukemia Treatment Product Offered
  12.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Ambit Biosciences Corporation News
12.2 Celgene Corporation
  12.2.1 Company Details
  12.2.2 Acute Myeloid Leukemia Treatment Product Offered
  12.2.3 Celgene Corporation Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Celgene Corporation News
12.3 Cephalon
  12.3.1 Company Details
  12.3.2 Acute Myeloid Leukemia Treatment Product Offered
  12.3.3 Cephalon Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Cephalon News
12.4 Clavis Pharma
  12.4.1 Company Details
  12.4.2 Acute Myeloid Leukemia Treatment Product Offered
  12.4.3 Clavis Pharma Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Clavis Pharma News
12.5 Eisai
  12.5.1 Company Details
  12.5.2 Acute Myeloid Leukemia Treatment Product Offered
  12.5.3 Eisai Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Eisai News
12.6 Genzyme Corporation
  12.6.1 Company Details
  12.6.2 Acute Myeloid Leukemia Treatment Product Offered
  12.6.3 Genzyme Corporation Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Genzyme Corporation News
12.7 Sunesis Pharmaceuticals
  12.7.1 Company Details
  12.7.2 Acute Myeloid Leukemia Treatment Product Offered
  12.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Sunesis Pharmaceuticals News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Acute Myeloid Leukemia Treatment
Table Product Specifications of Acute Myeloid Leukemia Treatment
Figure Acute Myeloid Leukemia Treatment Report Years Considered
Figure Market Research Methodology
Figure Global Acute Myeloid Leukemia Treatment Consumption Growth Rate 2013-2023 (K Units)
Figure Global Acute Myeloid Leukemia Treatment Value Growth Rate 2013-2023 ($ Millions)
Table Acute Myeloid Leukemia Treatment Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of DC regimen
Table Major Players of DC regimen
Figure Product Picture of AVD Regimen
Table Major Players of AVD Regimen
Figure Product Picture of VCD regimen
Table Major Players of VCD regimen
Table Global Consumption Sales by Type (2013-2018)
Table Global Acute Myeloid Leukemia Treatment Consumption Market Share by Type (2013-2018)
Figure Global Acute Myeloid Leukemia Treatment Consumption Market Share by Type (2013-2018)
Table Global Acute Myeloid Leukemia Treatment Revenue by Type (2013-2018) ($ million)
Table Global Acute Myeloid Leukemia Treatment Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Acute Myeloid Leukemia Treatment Value Market Share by Type (2013-2018)
Table Global Acute Myeloid Leukemia Treatment Sale Price by Type (2013-2018)
Figure Acute Myeloid Leukemia Treatment Consumed in Hospital
Figure Global Acute Myeloid Leukemia Treatment Market: Hospital (2013-2018) (K Units)
Figure Global Acute Myeloid Leukemia Treatment Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Acute Myeloid Leukemia Treatment Consumed in Clinic
Figure Global Acute Myeloid Leukemia Treatment Market: Clinic (2013-2018) (K Units)
Figure Global Acute Myeloid Leukemia Treatment Market: Clinic (2013-2018) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Figure Acute Myeloid Leukemia Treatment Consumed in Others
Figure Global Acute Myeloid Leukemia Treatment Market: Others (2013-2018) (K Units)
Figure Global Acute Myeloid Leukemia Treatment Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Acute Myeloid Leukemia Treatment Consumption Market Share by Application (2013-2018)
Figure Global Acute Myeloid Leukemia Treatment Consumption Market Share by Application (2013-2018)
Table Global Acute Myeloid Leukemia Treatment Value by Application (2013-2018)
Table Global Acute Myeloid Leukemia Treatment Value Market Share by Application (2013-2018)
Figure Global Acute Myeloid Leukemia Treatment Value Market Share by Application (2013-2018)
Table Global Acute Myeloid Leukemia Treatment Sale Price by Application (2013-2018)
Table Global Acute Myeloid Leukemia Treatment Sales by Players (2016-2018) (K Units)
Table Global Acute Myeloid Leukemia Treatment Sales Market Share by Players (2016-2018)
Figure Global Acute Myeloid Leukemia Treatment Sales Market Share by Players in 2016
Figure Global Acute Myeloid Leukemia Treatment Sales Market Share by Players in 2017
Table Global Acute Myeloid Leukemia Treatment Revenue by Players (2016-2018) ($ Millions)
Table Global Acute Myeloid Leukemia Treatment Revenue Market Share by Players (2016-2018)
Figure Global Acute Myeloid Leukemia Treatment Revenue Market Share by Players in 2016
Figure Global Acute Myeloid Leukemia Treatment Revenue Market Share by Players in 2017
Table Global Acute Myeloid Leukemia Treatment Sale Price by Players (2016-2018)
Figure Global Acute Myeloid Leukemia Treatment Sale Price by Players in 2017
Table Global Acute Myeloid Leukemia Treatment Manufacturing Base Distribution and Sales Area by Players
Table Players Acute Myeloid Leukemia Treatment Products Offered
Table Acute Myeloid Leukemia Treatment Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Acute Myeloid Leukemia Treatment Consumption by Regions 2013-2018 (K Units)
Table Global Acute Myeloid Leukemia Treatment Consumption Market Share by Regions 2013-2018
Figure Global Acute Myeloid Leukemia Treatment Consumption Market Share by Regions 2013-2018
Table Global Acute Myeloid Leukemia Treatment Value by Regions 2013-2018 ($ Millions)
Table Global Acute Myeloid Leukemia Treatment Value Market Share by Regions 2013-2018
Figure Global Acute Myeloid Leukemia Treatment Value Market Share by Regions 2013-2018
Figure Americas Acute Myeloid Leukemia Treatment Consumption 2013-2018 (K Units)
Figure Americas Acute Myeloid Leukemia Treatment Value 2013-2018 ($ Millions)
Figure APAC Acute Myeloid Leukemia Treatment Consumption 2013-2018 (K Units)
Figure APAC Acute Myeloid Leukemia Treatment Value 2013-2018 ($ Millions)
Figure Europe Acute Myeloid Leukemia Treatment Consumption 2013-2018 (K Units)
Figure Europe Acute Myeloid Leukemia Treatment Value 2013-2018 ($ Millions)
Figure Middle East & Africa Acute Myeloid Leukemia Treatment Consumption 2013-2018 (K Units)
Figure Middle East & Africa Acute Myeloid Leukemia Treatment Value 2013-2018 ($ Millions)
Table Americas Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018) (K Units)
Table Americas Acute Myeloid Leukemia Treatment Consumption Market Share by Countries (2013-2018)
Figure Americas Acute Myeloid Leukemia Treatment Consumption Market Share by Countries in 2017
Table Americas Acute Myeloid Leukemia Treatment Value by Countries (2013-2018) ($ Millions)
Table Americas Acute Myeloid Leukemia Treatment Value Market Share by Countries (2013-2018)
Figure Americas Acute Myeloid Leukemia Treatment Value Market Share by Countries in 2017
Table Americas Acute Myeloid Leukemia Treatment Consumption by Type (2013-2018) (K Units)
Table Americas Acute Myeloid Leukemia Treatment Consumption Market Share by Type (2013-2018)
Figure Americas Acute Myeloid Leukemia Treatment Consumption Market Share by Type in 2017
Table Americas Acute Myeloid Leukemia Treatment Consumption by Application (2013-2018) (K Units)
Table Americas Acute Myeloid Leukemia Treatment Consumption Market Share by Application (2013-2018)
Figure Americas Acute Myeloid Leukemia Treatment Consumption Market Share by Application in 2017
Figure United States Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure United States Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Canada Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Canada Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Mexico Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Mexico Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Table APAC Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018) (K Units)
Table APAC Acute Myeloid Leukemia Treatment Consumption Market Share by Countries (2013-2018)
Figure APAC Acute Myeloid Leukemia Treatment Consumption Market Share by Countries in 2017
Table APAC Acute Myeloid Leukemia Treatment Value by Countries (2013-2018) ($ Millions)
Table APAC Acute Myeloid Leukemia Treatment Value Market Share by Countries (2013-2018)
Figure APAC Acute Myeloid Leukemia Treatment Value Market Share by Countries in 2017
Table APAC Acute Myeloid Leukemia Treatment Consumption by Type (2013-2018) (K Units)
Table APAC Acute Myeloid Leukemia Treatment Consumption Market Share by Type (2013-2018)
Figure APAC Acute Myeloid Leukemia Treatment Consumption Market Share by Type in 2017
Table APAC Acute Myeloid Leukemia Treatment Consumption by Application (2013-2018) (K Units)
Table APAC Acute Myeloid Leukemia Treatment Consumption Market Share by Application (2013-2018)
Figure APAC Acute Myeloid Leukemia Treatment Consumption Market Share by Application in 2017
Figure China Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure China Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Japan Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Japan Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Korea Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Korea Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure India Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure India Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Australia Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Australia Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Table Europe Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018) (K Units)
Table Europe Acute Myeloid Leukemia Treatment Consumption Market Share by Countries (2013-2018)
Figure Europe Acute Myeloid Leukemia Treatment Consumption Market Share by Countries in 2017
Table Europe Acute Myeloid Leukemia Treatment Value by Countries (2013-2018) ($ Millions)
Table Europe Acute Myeloid Leukemia Treatment Value Market Share by Countries (2013-2018)
Figure Europe Acute Myeloid Leukemia Treatment Value Market Share by Countries in 2017
Table Europe Acute Myeloid Leukemia Treatment Consumption by Type (2013-2018) (K Units)
Table Europe Acute Myeloid Leukemia Treatment Consumption Market Share by Type (2013-2018)
Figure Europe Acute Myeloid Leukemia Treatment Consumption Market Share by Type in 2017
Table Europe Acute Myeloid Leukemia Treatment Consumption by Application (2013-2018) (K Units)
Table Europe Acute Myeloid Leukemia Treatment Consumption Market Share by Application (2013-2018)
Figure Europe Acute Myeloid Leukemia Treatment Consumption Market Share by Application in 2017
Figure Germany Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Germany Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure France Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure France Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure UK Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure UK Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Italy Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Italy Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Russia Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Russia Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Spain Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Spain Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Acute Myeloid Leukemia Treatment Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Market Share by Countries in 2017
Table Middle East & Africa Acute Myeloid Leukemia Treatment Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Acute Myeloid Leukemia Treatment Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Acute Myeloid Leukemia Treatment Value Market Share by Countries in 2017
Table Middle East & Africa Acute Myeloid Leukemia Treatment Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Market Share by Type in 2017
Table Middle East & Africa Acute Myeloid Leukemia Treatment Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Market Share by Application in 2017
Figure Egypt Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Egypt Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure South Africa Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure South Africa Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Israel Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Israel Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure Turkey Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure Turkey Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Acute Myeloid Leukemia Treatment Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Acute Myeloid Leukemia Treatment Value Growth 2013-2018 ($ Millions)
Table Acute Myeloid Leukemia Treatment Distributors List
Table Acute Myeloid Leukemia Treatment Customer List
Figure Global Acute Myeloid Leukemia Treatment Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Acute Myeloid Leukemia Treatment Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Acute Myeloid Leukemia Treatment Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Acute Myeloid Leukemia Treatment Consumption Market Forecast by Regions
Table Global Acute Myeloid Leukemia Treatment Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Acute Myeloid Leukemia Treatment Value Market Share Forecast by Regions
Figure Americas Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Americas Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure APAC Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure APAC Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Europe Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Europe Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Middle East & Africa Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Middle East & Africa Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure United States Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure United States Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Canada Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Canada Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Mexico Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Mexico Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Brazil Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Brazil Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure China Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure China Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Japan Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Japan Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Korea Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Korea Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Southeast Asia Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Southeast Asia Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure India Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure India Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Australia Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Australia Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Germany Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Germany Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure France Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure France Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure UK Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure UK Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Italy Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Italy Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Russia Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Russia Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Spain Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Spain Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Egypt Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Egypt Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure South Africa Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure South Africa Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Israel Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Israel Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure Turkey Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure Turkey Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Figure GCC Countries Acute Myeloid Leukemia Treatment Consumption 2018-2023 (K Units)
Figure GCC Countries Acute Myeloid Leukemia Treatment Value 2018-2023 ($ Millions)
Table Global Acute Myeloid Leukemia Treatment Consumption Forecast by Type (2018-2023) (K Units)
Table Global Acute Myeloid Leukemia Treatment Consumption Market Share Forecast by Type (2018-2023)
Table Global Acute Myeloid Leukemia Treatment Value Forecast by Type (2018-2023) ($ Millions)
Table Global Acute Myeloid Leukemia Treatment Value Market Share Forecast by Type (2018-2023)
Table Global Acute Myeloid Leukemia Treatment Consumption Forecast by Application (2018-2023) (K Units)
Table Global Acute Myeloid Leukemia Treatment Consumption Market Share Forecast by Application (2018-2023)
Table Global Acute Myeloid Leukemia Treatment Value Forecast by Application (2018-2023) ($ Millions)
Table Global Acute Myeloid Leukemia Treatment Value Market Share Forecast by Application (2018-2023)
Table Ambit Biosciences Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Market Share (2016-2018)
Table Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Corporation Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Celgene Corporation Acute Myeloid Leukemia Treatment Market Share (2016-2018)
Table Cephalon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cephalon Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Cephalon Acute Myeloid Leukemia Treatment Market Share (2016-2018)
Table Clavis Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Clavis Pharma Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Clavis Pharma Acute Myeloid Leukemia Treatment Market Share (2016-2018)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eisai Acute Myeloid Leukemia Treatment Market Share (2016-2018)
Table Genzyme Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genzyme Corporation Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Genzyme Corporation Acute Myeloid Leukemia Treatment Market Share (2016-2018)
Table Sunesis Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Market Share (2016-2018)